Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The future of CFTR modulating therapies for cystic fibrosis.

Current opinion in pulmonary medicine - 1 Nov 2015

Davies Jane C

Abstract excerpt

PURPOSE OF REVIEW: Huge progress has been made over the last few years in the field of small molecule therapies targeting cystic fibrosis transmembrane conductance regulator (CFTR), the protein defective in patients with cystic fibrosis. This review describes the progress and areas of future research. RECENT FINDINGS: Ivacaftor is the first drug of its kind to be licensed for clinical use in patients with a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cystic Fibrosis
Share to Cystic Fibrosis Transmembrane Conductance Regulator
Share to CFTR gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Precision Medicine

Source

Identifiers

PMID: 26390337
DOI: 10.1097/MCP.0000000000000211

Genes

CFTR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The future of CFTR modulating therapies for cystic fibrosis.PMID 26390337Read ↗

Repairing mutated proteins--development of small molecules targeting defects in the cystic fibrosis transmembrane conductance regulator.Semantic proximity Read ↗

New Therapeutic Approaches to Modulate and Correct Cystic Fibrosis Transmembrane Conductance Regulator.Semantic proximity Read ↗

Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectivesSemantic proximity Read ↗

New and emerging targeted therapies for cystic fibrosis.Semantic proximity Read ↗

CFTR Modulators: From Mechanism to Targeted Therapeutics.Semantic proximity Read ↗

[Treatment of Cystic Fibrosis with CFTR Modulators].Semantic proximity Read ↗

Cystic fibrosis transmembrane conductance regulator modulators: precision medicine in cystic fibrosisSemantic proximity Read ↗

Emerging medicines to improve the basic defect in cystic fibrosis.Semantic proximity Read ↗

Cystic Fibrosis Transmembrane Conductance Regulator–Modifying Medications: The Future of Cystic Fibrosis TreatmentSemantic proximity Read ↗

The revolution of personalized pharmacotherapies for cystic fibrosis: what does the future hold?Semantic proximity Read ↗

Discovery of CFTR modulators for the treatment of cystic fibrosis.Semantic proximity Read ↗

Small-molecule drugs for cystic fibrosis: Where are we now?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.